Australia’s COVID-19 Response and Our Critical Areas for Learning

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

This will not be a popular share.

This article reveals some critical areas for learning for Australia’s #clinicaltrials sector and our public funders, and calls out a lack of coordinated and strategically planned response to the #Covid19 pandemic.

As a result we have too many studies, with abysmally low #recruitment numbers (if the data is correct) and a lack of meaningful data to help us learn from the #pandemic.

It points to the issues that continue to constrain us: a lack of national coordination in this country (like the UK model), a paucity of public awareness about the role of clinical trials and a governance system that must be improved.

There are so many things to celebrate about our strong and high quality clinical trials sector, but now is the time to address our areas of weakness and bring long awaited change.

#clinicaltrials #researchgovernance #Covid19 #frontdoor#publiclyfundedresearch #clinicaltrialsawareness #publicawareness

Link to original article:

Receive exclusive offers by signing up to our mailing list